Daré Bioscience's Q4 2024 earnings highlight a dual-path strategy for Sildenafil Cream, targeting 2025 revenue with 503B compounding while advancing ...

At the beginning of March the U.S. government seized over 100 erectile dysfunction pills and thousands of dollars in shirts ...

The company projects initial revenue generation from its Sildenafil Cream formulation in Q4 2025, backed by its 503B compounding strategy. Daré plans to provide updates in Q2 2025 on strategic ...

With increasing demand for needed treatments designed for women, Daré is taking action to make its proprietary Sildenafil ...

Q4 2024 Earnings Call Transcript March 31, 2025 Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.61, ...

Maintaining health and wellness can be daunting in today’s fast-paced world. Many individuals struggle with weight management, sexual wellness, and overall well-being. Enter JRNYS, a telemedicine ...

GETTING ready for a big night out on the town meant one thing for Rich Mac – digging out a sachet of a super-strength sex drug in the hope of striking it lucky. It was a risky move ...

Cork’s pharmaceutical industry, vital to the local economy, is at risk as US trade policies threaten small towns reliant on ...

Welcome to the conference call hosted by Dare Bioscience to review the company's 2024 financial results and to provide a business update. This call is being recorded. My name is Jericho, and I'll be ...

Several observations from preclinical and short-term clinical studies support a role for sildenafil in the treatment of heart failure patients. The following discussion briefly considers each of ...

Experts warn that ExtenZe may not be safe to use for erectile dysfunction. Read on to find out why and to learn about its ...

ALONG with sneezing and sore eyes, could hay fever be causing you problems in the bedroom? In the UK, it’s estimated that ...